No Data
No Data
IX Biopharma Welcomes Aging Expert to Advisory Board
IX Biopharma Schedules Extraordinary General Meeting for Scheme Extensions
Financial Statements and Related Announcement-Auditor's Comments of Accounts
IX Biopharma Advances Wafermine Out-Licensing, Starts Preclinical Trials for IXB 401
New Study Demonstrates That SL-NAD+ Delivers NAD+ Into Cells
IX Biopharma's New Wafer Revolutionizes NAD+ Supplementation
No Data
No Data
hh488 : They trying to release some positive news prior to the payment of the rights. So don't get caught & jump in right away!